News

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...
Dan Peer, a global pioneer in mRNA drug development and director of the Laboratory of ... is an mRNA-based vaccine delivered ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...
Coordinators of past immunization campaigns for other ailments are watching the COVID-19 vaccine development process closely, in hopes of heading off missteps that would undermine uptake and access.
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing the ...
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...